Sunshine Biopharma Inc. (SBFMW) Operating income 2016–2025
Sunshine Biopharma Inc. (SBFMW) annual operating income history from SEC filings — each fiscal year as reported.
-$6.2MFY2025 · since FY2016: -$993,108 → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.2M | -7.1% |
| FY2024 | -$5.8M | -21.5% |
| FY2023 | -$4.8M | +82.3% |
| FY2022 | -$27.0M | -1006.5% |
| FY2021 | -$2.4M | -323.0% |
| FY2020 | -$576,874 | +10.1% |
| FY2019 | -$641,636 | +44.9% |
| FY2018 | -$1.2M | -35.8% |
| FY2017 | -$857,190 | +13.7% |
| FY2016 | -$993,108 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net incomeSBFMW Net marginSBFMW Gross profitSBFMW Gross marginSBFMW Operating marginSBFMW Operating cash flowSBFMW Free cash flowSBFMW Capital expendituresSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →